Interactions between e-400-clear(vitamin E) and Anisindione (anisindione)
vitamin E and anisindione (Moderate Drug-Drug)
MANAGEMENT: The INR should be monitored closely and anticoagulant dosage adjusted accordingly during concomitant therapy, particularly following initiation or discontinuation of vitamin E therapy in patients who are stabilized on an oral anticoagulant. Patients should be advised to notify their physicians if they experience any signs of excessive anticoagulation, such as unusual or prolonged bleeding, bruising, vomiting, change in stool or urine color, headache, dizziness, or weakness.








